Lavior and Lovell partner to expand federal access to wound care products

Lavior and Lovell Government Services announced a partnership on June 22, 2026, to broaden access to Lavior’s botanical wound and skin care products across VA, DoD and IHS channels. The deal is designed to streamline federal purchasing and support care for veterans, active-duty service members and other federal patients.

Why it matters: - The partnership could make it easier for VA, DoD and IHS providers to buy wound and skin care products for veterans, active-duty personnel and other federal patients. - Lavior products carry HCPCS reimbursement codes on several items, which can simplify reimbursement and procurement for government buyers. - The agreement also supports SDVOSB procurement goals inside federal healthcare systems.

What happened: - Lavior and Lovell Government Services announced a partnership on June 22, 2026. - Lovell will serve as Lavior’s Service-Disabled Veteran-Owned Small Business vendor. - The collaboration is aimed at expanding access to Lavior’s advanced botanical wound and skin care products across the Veterans Health Administration, Military Health System and Indian Health Service.

The details: - Lavior’s portfolio includes Diabetic Wound Therapy Gel, Advanced Diabetic Wound Hydrogel, Multipurpose Wound Gel, Post-Surgical Skin Barrier Gel and Diabetic Skin Barrier Cream. - The products are formulated for diabetic and post-procedure skin. - Lavior says the formulations are backed by 16 years of research and use the bioactive properties of the Inula viscosa AGS-RIED botanical species. - The products are U.S.-made and are designed to maintain a moist, protective environment that supports wound healing and the skin’s natural barrier. - Several products carry HCPCS reimbursement codes A6248 and A6250 as wound dressings and skin protectants/sealants. - Lavior products are available through the Department of Veterans Affairs Federal Supply Schedule, GSA Advantage, the Defense Logistics Agency’s Electronic Catalog and the Department of Defense’s Distribution and Pricing Agreement. - Lovell will help position the portfolio for streamlined access through federal contracting channels.

Between the lines: - The partnership gives Lavior a federal sales pathway through a vendor already built for government procurement. - For federal providers, the deal could reduce acquisition friction while adding another wound care option with reimbursement coding attached. - Chris Lovell said the partnership is meant to connect government healthcare providers with solutions that can improve patient outcomes and quality of care. - Gilad Savion said the goal is to help federal providers access the formulations more efficiently across the VA, DoD and IHS.

What's next: - Lavior and Lovell will work to expand product availability through federal contracting vehicles already used by government buyers. - The companies are positioning the portfolio for broader adoption across veteran and military care settings. - Lavior and Lovell also point to future growth tied to federal revenue and government contracting opportunities.

The bottom line: - The partnership is a procurement play as much as a healthcare one, aiming to move Lavior’s wound care products deeper into federal systems by using Lovell’s SDVOSB contracting infrastructure. - More information is available at Lavior and Lovell Government Services.